Duchenne muscular dystrophy (DMD) is a genetic disorder characterized by progressive muscle degeneration and weakness. DMD is caused due to alteration in gene sequence coding for dystrophin protein, which is present the muscle. Duchenne muscular dystrophy (DMD) drugs are drugs used for treatment of Duchenne muscular dystrophy (DMD) disease, which include three approved products: Exondys51, Translarna and Emflaza.
Based on the Duchenne Muscular Dystrophy Drugs market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.

In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.

Key players in the global Duchenne Muscular Dystrophy Drugs market covered in Chapter 5:
Capricor Therapeutics
Taiho Pharmaceutical
Acceleron Pharma
Catabasis Pharmaceuticals
Bristol-Myers Squibb
Janssen Pharmaceuticals
Asklepios BioPharmaceuticals
Marathon Pharmaceuticals
Nobelpharma
PTC Therapeutics
Italfarmaco
Akashi Therapeutics
Summit Therapeutics
Nippon Shinyaku
Pfizer
BioMarin Pharmaceutical
Lexicon Pharmaceuticals
Santhera Pharmaceuticals
Sarepta Therapeutics
Eli Lilly

In Chapter 6, on the basis of types, the Duchenne Muscular Dystrophy Drugs market from 2015 to 2025 is primarily split into:
Exondys51
Translarna
Emflaza

In Chapter 7, on the basis of applications, the Duchenne Muscular Dystrophy Drugs market from 2015 to 2025 covers:
Hospitals
Home care settings
Clinics

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025

Table of Content

1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Duchenne Muscular Dystrophy Drugs Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis

2. Market Dynamics
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact

3 Associated Industry Assessment
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain

4 Market Competitive Landscape
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 M&A and Expansion Plans

5 Analysis of Leading Companies
5.1 Capricor Therapeutics
5.1.1 Capricor Therapeutics Company Profile
5.1.2 Capricor Therapeutics Business Overview
5.1.3 Capricor Therapeutics Duchenne Muscular Dystrophy Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 Capricor Therapeutics Duchenne Muscular Dystrophy Drugs Products Introduction
5.2 Taiho Pharmaceutical
5.2.1 Taiho Pharmaceutical Company Profile
5.2.2 Taiho Pharmaceutical Business Overview
5.2.3 Taiho Pharmaceutical Duchenne Muscular Dystrophy Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 Taiho Pharmaceutical Duchenne Muscular Dystrophy Drugs Products Introduction
5.3 Acceleron Pharma
5.3.1 Acceleron Pharma Company Profile
5.3.2 Acceleron Pharma Business Overview
5.3.3 Acceleron Pharma Duchenne Muscular Dystrophy Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 Acceleron Pharma Duchenne Muscular Dystrophy Drugs Products Introduction
5.4 Catabasis Pharmaceuticals
5.4.1 Catabasis Pharmaceuticals Company Profile
5.4.2 Catabasis Pharmaceuticals Business Overview
5.4.3 Catabasis Pharmaceuticals Duchenne Muscular Dystrophy Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 Catabasis Pharmaceuticals Duchenne Muscular Dystrophy Drugs Products Introduction
5.5 Bristol-Myers Squibb
5.5.1 Bristol-Myers Squibb Company Profile
5.5.2 Bristol-Myers Squibb Business Overview
5.5.3 Bristol-Myers Squibb Duchenne Muscular Dystrophy Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.5.4 Bristol-Myers Squibb Duchenne Muscular Dystrophy Drugs Products Introduction
5.6 Janssen Pharmaceuticals
5.6.1 Janssen Pharmaceuticals Company Profile
5.6.2 Janssen Pharmaceuticals Business Overview
5.6.3 Janssen Pharmaceuticals Duchenne Muscular Dystrophy Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.6.4 Janssen Pharmaceuticals Duchenne Muscular Dystrophy Drugs Products Introduction
5.7 Asklepios BioPharmaceuticals
5.7.1 Asklepios BioPharmaceuticals Company Profile
5.7.2 Asklepios BioPharmaceuticals Business Overview
5.7.3 Asklepios BioPharmaceuticals Duchenne Muscular Dystrophy Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.7.4 Asklepios BioPharmaceuticals Duchenne Muscular Dystrophy Drugs Products Introduction
5.8 Marathon Pharmaceuticals
5.8.1 Marathon Pharmaceuticals Company Profile
5.8.2 Marathon Pharmaceuticals Business Overview
5.8.3 Marathon Pharmaceuticals Duchenne Muscular Dystrophy Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.8.4 Marathon Pharmaceuticals Duchenne Muscular Dystrophy Drugs Products Introduction
5.9 Nobelpharma
5.9.1 Nobelpharma Company Profile
5.9.2 Nobelpharma Business Overview
5.9.3 Nobelpharma Duchenne Muscular Dystrophy Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.9.4 Nobelpharma Duchenne Muscular Dystrophy Drugs Products Introduction
5.10 PTC Therapeutics
5.10.1 PTC Therapeutics Company Profile
5.10.2 PTC Therapeutics Business Overview
5.10.3 PTC Therapeutics Duchenne Muscular Dystrophy Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.10.4 PTC Therapeutics Duchenne Muscular Dystrophy Drugs Products Introduction
5.11 Italfarmaco
5.11.1 Italfarmaco Company Profile
5.11.2 Italfarmaco Business Overview
5.11.3 Italfarmaco Duchenne Muscular Dystrophy Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.11.4 Italfarmaco Duchenne Muscular Dystrophy Drugs Products Introduction
5.12 Akashi Therapeutics
5.12.1 Akashi Therapeutics Company Profile
5.12.2 Akashi Therapeutics Business Overview
5.12.3 Akashi Therapeutics Duchenne Muscular Dystrophy Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.12.4 Akashi Therapeutics Duchenne Muscular Dystrophy Drugs Products Introduction
5.13 Summit Therapeutics
5.13.1 Summit Therapeutics Company Profile
5.13.2 Summit Therapeutics Business Overview
5.13.3 Summit Therapeutics Duchenne Muscular Dystrophy Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.13.4 Summit Therapeutics Duchenne Muscular Dystrophy Drugs Products Introduction
5.14 Nippon Shinyaku
5.14.1 Nippon Shinyaku Company Profile
5.14.2 Nippon Shinyaku Business Overview
5.14.3 Nippon Shinyaku Duchenne Muscular Dystrophy Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.14.4 Nippon Shinyaku Duchenne Muscular Dystrophy Drugs Products Introduction
5.15 Pfizer
5.15.1 Pfizer Company Profile
5.15.2 Pfizer Business Overview
5.15.3 Pfizer Duchenne Muscular Dystrophy Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.15.4 Pfizer Duchenne Muscular Dystrophy Drugs Products Introduction
5.16 BioMarin Pharmaceutical
5.16.1 BioMarin Pharmaceutical Company Profile
5.16.2 BioMarin Pharmaceutical Business Overview
5.16.3 BioMarin Pharmaceutical Duchenne Muscular Dystrophy Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.16.4 BioMarin Pharmaceutical Duchenne Muscular Dystrophy Drugs Products Introduction
5.17 Lexicon Pharmaceuticals
5.17.1 Lexicon Pharmaceuticals Company Profile
5.17.2 Lexicon Pharmaceuticals Business Overview
5.17.3 Lexicon Pharmaceuticals Duchenne Muscular Dystrophy Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.17.4 Lexicon Pharmaceuticals Duchenne Muscular Dystrophy Drugs Products Introduction
5.18 Santhera Pharmaceuticals
5.18.1 Santhera Pharmaceuticals Company Profile
5.18.2 Santhera Pharmaceuticals Business Overview
5.18.3 Santhera Pharmaceuticals Duchenne Muscular Dystrophy Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.18.4 Santhera Pharmaceuticals Duchenne Muscular Dystrophy Drugs Products Introduction
5.19 Sarepta Therapeutics
5.19.1 Sarepta Therapeutics Company Profile
5.19.2 Sarepta Therapeutics Business Overview
5.19.3 Sarepta Therapeutics Duchenne Muscular Dystrophy Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.19.4 Sarepta Therapeutics Duchenne Muscular Dystrophy Drugs Products Introduction
5.20 Eli Lilly
5.20.1 Eli Lilly Company Profile
5.20.2 Eli Lilly Business Overview
5.20.3 Eli Lilly Duchenne Muscular Dystrophy Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.20.4 Eli Lilly Duchenne Muscular Dystrophy Drugs Products Introduction

6 Market Analysis and Forecast, By Product Types
6.1 Global Duchenne Muscular Dystrophy Drugs Sales, Revenue and Market Share by Types (2015-2020)
6.1.1 Global Duchenne Muscular Dystrophy Drugs Sales and Market Share by Types (2015-2020)
6.1.2 Global Duchenne Muscular Dystrophy Drugs Revenue and Market Share by Types (2015-2020)
6.1.3 Global Duchenne Muscular Dystrophy Drugs Price by Types (2015-2020)
6.2 Global Duchenne Muscular Dystrophy Drugs Market Forecast by Types (2020-2025)
6.2.1 Global Duchenne Muscular Dystrophy Drugs Market Forecast Sales and Market Share by Types (2020-2025)
6.2.2 Global Duchenne Muscular Dystrophy Drugs Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global Duchenne Muscular Dystrophy Drugs Sales, Price and Growth Rate by Types (2015-2020)
6.3.1 Global Duchenne Muscular Dystrophy Drugs Sales, Price and Growth Rate of Exondys51
6.3.2 Global Duchenne Muscular Dystrophy Drugs Sales, Price and Growth Rate of Translarna
6.3.3 Global Duchenne Muscular Dystrophy Drugs Sales, Price and Growth Rate of Emflaza
6.4 Global Duchenne Muscular Dystrophy Drugs Market Revenue and Sales Forecast, by Types (2020-2025)
6.4.1 Exondys51 Market Revenue and Sales Forecast (2020-2025)
6.4.2 Translarna Market Revenue and Sales Forecast (2020-2025)
6.4.3 Emflaza Market Revenue and Sales Forecast (2020-2025)

7 Market Analysis and Forecast, By Applications
7.1 Global Duchenne Muscular Dystrophy Drugs Sales, Revenue and Market Share by Applications (2015-2020)
7.1.1 Global Duchenne Muscular Dystrophy Drugs Sales and Market Share by Applications (2015-2020)
7.1.2 Global Duchenne Muscular Dystrophy Drugs Revenue and Market Share by Applications (2015-2020)
7.2 Global Duchenne Muscular Dystrophy Drugs Market Forecast by Applications (2020-2025)
7.2.1 Global Duchenne Muscular Dystrophy Drugs Market Forecast Sales and Market Share by Applications (2020-2025)
7.2.2 Global Duchenne Muscular Dystrophy Drugs Market Forecast Revenue and Market Share by Applications (2020-2025)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
7.3.1 Global Duchenne Muscular Dystrophy Drugs Revenue, Sales and Growth Rate of Hospitals (2015-2020)
7.3.2 Global Duchenne Muscular Dystrophy Drugs Revenue, Sales and Growth Rate of Home care settings (2015-2020)
7.3.3 Global Duchenne Muscular Dystrophy Drugs Revenue, Sales and Growth Rate of Clinics (2015-2020)
7.4 Global Duchenne Muscular Dystrophy Drugs Market Revenue and Sales Forecast, by Applications (2020-2025)
7.4.1 Hospitals Market Revenue and Sales Forecast (2020-2025)
7.4.2 Home care settings Market Revenue and Sales Forecast (2020-2025)
7.4.3 Clinics Market Revenue and Sales Forecast (2020-2025)

8 Market Analysis and Forecast, By Regions
8.1 Global Duchenne Muscular Dystrophy Drugs Sales by Regions (2015-2020)
8.2 Global Duchenne Muscular Dystrophy Drugs Market Revenue by Regions (2015-2020)
8.3 Global Duchenne Muscular Dystrophy Drugs Market Forecast by Regions (2020-2025)

9 North America Duchenne Muscular Dystrophy Drugs Market Analysis
9.1 Market Overview and Prospect Analysis
9.2 North America Duchenne Muscular Dystrophy Drugs Market Sales and Growth Rate (2015-2020)
9.3 North America Duchenne Muscular Dystrophy Drugs Market Revenue and Growth Rate (2015-2020)
9.4 North America Duchenne Muscular Dystrophy Drugs Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America Duchenne Muscular Dystrophy Drugs Market Analysis by Country
9.6.1 U.S. Duchenne Muscular Dystrophy Drugs Sales and Growth Rate
9.6.2 Canada Duchenne Muscular Dystrophy Drugs Sales and Growth Rate
9.6.3 Mexico Duchenne Muscular Dystrophy Drugs Sales and Growth Rate

10 Europe Duchenne Muscular Dystrophy Drugs Market Analysis
10.1 Market Overview and Prospect Analysis
10.2 Europe Duchenne Muscular Dystrophy Drugs Market Sales and Growth Rate (2015-2020)
10.3 Europe Duchenne Muscular Dystrophy Drugs Market Revenue and Growth Rate (2015-2020)
10.4 Europe Duchenne Muscular Dystrophy Drugs Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe Duchenne Muscular Dystrophy Drugs Market Analysis by Country
10.6.1 Germany Duchenne Muscular Dystrophy Drugs Sales and Growth Rate
10.6.2 United Kingdom Duchenne Muscular Dystrophy Drugs Sales and Growth Rate
10.6.3 France Duchenne Muscular Dystrophy Drugs Sales and Growth Rate
10.6.4 Italy Duchenne Muscular Dystrophy Drugs Sales and Growth Rate
10.6.5 Spain Duchenne Muscular Dystrophy Drugs Sales and Growth Rate
10.6.6 Russia Duchenne Muscular Dystrophy Drugs Sales and Growth Rate

11 Asia-Pacific Duchenne Muscular Dystrophy Drugs Market Analysis
11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific Duchenne Muscular Dystrophy Drugs Market Sales and Growth Rate (2015-2020)
11.3 Asia-Pacific Duchenne Muscular Dystrophy Drugs Market Revenue and Growth Rate (2015-2020)
11.4 Asia-Pacific Duchenne Muscular Dystrophy Drugs Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific Duchenne Muscular Dystrophy Drugs Market Analysis by Country
11.6.1 China Duchenne Muscular Dystrophy Drugs Sales and Growth Rate
11.6.2 Japan Duchenne Muscular Dystrophy Drugs Sales and Growth Rate
11.6.3 South Korea Duchenne Muscular Dystrophy Drugs Sales and Growth Rate
11.6.4 Australia Duchenne Muscular Dystrophy Drugs Sales and Growth Rate
11.6.5 India Duchenne Muscular Dystrophy Drugs Sales and Growth Rate

12 South America Duchenne Muscular Dystrophy Drugs Market Analysis
12.1 Market Overview and Prospect Analysis
12.2 South America Duchenne Muscular Dystrophy Drugs Market Sales and Growth Rate (2015-2020)
12.3 South America Duchenne Muscular Dystrophy Drugs Market Revenue and Growth Rate (2015-2020)
12.4 South America Duchenne Muscular Dystrophy Drugs Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America Duchenne Muscular Dystrophy Drugs Market Analysis by Country
12.6.1 Brazil Duchenne Muscular Dystrophy Drugs Sales and Growth Rate
12.6.2 Argentina Duchenne Muscular Dystrophy Drugs Sales and Growth Rate
12.6.3 Columbia Duchenne Muscular Dystrophy Drugs Sales and Growth Rate

13 Middle East and Africa Duchenne Muscular Dystrophy Drugs Market Analysis
13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa Duchenne Muscular Dystrophy Drugs Market Sales and Growth Rate (2015-2020)
13.3 Middle East and Africa Duchenne Muscular Dystrophy Drugs Market Revenue and Growth Rate (2015-2020)
13.4 Middle East and Africa Duchenne Muscular Dystrophy Drugs Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa Duchenne Muscular Dystrophy Drugs Market Analysis by Country
13.6.1 UAE Duchenne Muscular Dystrophy Drugs Sales and Growth Rate
13.6.2 Egypt Duchenne Muscular Dystrophy Drugs Sales and Growth Rate
13.6.3 South Africa Duchenne Muscular Dystrophy Drugs Sales and Growth Rate

14 Conclusions and Recommendations
14.1 Key Market Findings and Prospects
14.2 Advice for Investors

15 Appendix
15.1 Methodology
15.2 Research Data Source

List of Tables and Figures

Figure Product Picture
Figure Global Duchenne Muscular Dystrophy Drugs Market Size and Growth Rate 2015-2025
Table Duchenne Muscular Dystrophy Drugs Key Market Segments
Figure Global Duchenne Muscular Dystrophy Drugs Market Revenue ($) Segment by Type from 2015-2020
Figure Global Duchenne Muscular Dystrophy Drugs Market Revenue ($) Segment by Applications from 2015-2020
Table SWOT Analysis
Figure Global COVID-19 Status
Figure Supply Chain
Table Major Players Headquarters, and Service Area of Duchenne Muscular Dystrophy Drugs
Table Major Players Revenue in 2019
Figure Major Players Revenue Share in 2019
Table Capricor Therapeutics Company Profile
Table Capricor Therapeutics Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Capricor Therapeutics Production and Growth Rate
Figure Capricor Therapeutics Market Revenue ($) Market Share 2015-2020
Table Taiho Pharmaceutical Company Profile
Table Taiho Pharmaceutical Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Taiho Pharmaceutical Production and Growth Rate
Figure Taiho Pharmaceutical Market Revenue ($) Market Share 2015-2020
Table Acceleron Pharma Company Profile
Table Acceleron Pharma Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Acceleron Pharma Production and Growth Rate
Figure Acceleron Pharma Market Revenue ($) Market Share 2015-2020
Table Catabasis Pharmaceuticals Company Profile
Table Catabasis Pharmaceuticals Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Catabasis Pharmaceuticals Production and Growth Rate
Figure Catabasis Pharmaceuticals Market Revenue ($) Market Share 2015-2020
Table Bristol-Myers Squibb Company Profile
Table Bristol-Myers Squibb Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Bristol-Myers Squibb Production and Growth Rate
Figure Bristol-Myers Squibb Market Revenue ($) Market Share 2015-2020
Table Janssen Pharmaceuticals Company Profile
Table Janssen Pharmaceuticals Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Janssen Pharmaceuticals Production and Growth Rate
Figure Janssen Pharmaceuticals Market Revenue ($) Market Share 2015-2020
Table Asklepios BioPharmaceuticals Company Profile
Table Asklepios BioPharmaceuticals Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Asklepios BioPharmaceuticals Production and Growth Rate
Figure Asklepios BioPharmaceuticals Market Revenue ($) Market Share 2015-2020
Table Marathon Pharmaceuticals Company Profile
Table Marathon Pharmaceuticals Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Marathon Pharmaceuticals Production and Growth Rate
Figure Marathon Pharmaceuticals Market Revenue ($) Market Share 2015-2020
Table Nobelpharma Company Profile
Table Nobelpharma Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Nobelpharma Production and Growth Rate
Figure Nobelpharma Market Revenue ($) Market Share 2015-2020
Table PTC Therapeutics Company Profile
Table PTC Therapeutics Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure PTC Therapeutics Production and Growth Rate
Figure PTC Therapeutics Market Revenue ($) Market Share 2015-2020
Table Italfarmaco Company Profile
Table Italfarmaco Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Italfarmaco Production and Growth Rate
Figure Italfarmaco Market Revenue ($) Market Share 2015-2020
Table Akashi Therapeutics Company Profile
Table Akashi Therapeutics Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Akashi Therapeutics Production and Growth Rate
Figure Akashi Therapeutics Market Revenue ($) Market Share 2015-2020
Table Summit Therapeutics Company Profile
Table Summit Therapeutics Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Summit Therapeutics Production and Growth Rate
Figure Summit Therapeutics Market Revenue ($) Market Share 2015-2020
Table Nippon Shinyaku Company Profile
Table Nippon Shinyaku Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Nippon Shinyaku Production and Growth Rate
Figure Nippon Shinyaku Market Revenue ($) Market Share 2015-2020
Table Pfizer Company Profile
Table Pfizer Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Pfizer Production and Growth Rate
Figure Pfizer Market Revenue ($) Market Share 2015-2020
Table BioMarin Pharmaceutical Company Profile
Table BioMarin Pharmaceutical Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure BioMarin Pharmaceutical Production and Growth Rate
Figure BioMarin Pharmaceutical Market Revenue ($) Market Share 2015-2020
Table Lexicon Pharmaceuticals Company Profile
Table Lexicon Pharmaceuticals Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Lexicon Pharmaceuticals Production and Growth Rate
Figure Lexicon Pharmaceuticals Market Revenue ($) Market Share 2015-2020
Table Santhera Pharmaceuticals Company Profile
Table Santhera Pharmaceuticals Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Santhera Pharmaceuticals Production and Growth Rate
Figure Santhera Pharmaceuticals Market Revenue ($) Market Share 2015-2020
Table Sarepta Therapeutics Company Profile
Table Sarepta Therapeutics Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Sarepta Therapeutics Production and Growth Rate
Figure Sarepta Therapeutics Market Revenue ($) Market Share 2015-2020
Table Eli Lilly Company Profile
Table Eli Lilly Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Eli Lilly Production and Growth Rate
Figure Eli Lilly Market Revenue ($) Market Share 2015-2020
Table Global Duchenne Muscular Dystrophy Drugs Sales by Types (2015-2020)
Table Global Duchenne Muscular Dystrophy Drugs Sales Share by Types (2015-2020)
Table Global Duchenne Muscular Dystrophy Drugs Revenue ($) by Types (2015-2020)
Table Global Duchenne Muscular Dystrophy Drugs Revenue Share by Types (2015-2020)
Table Global Duchenne Muscular Dystrophy Drugs Price ($) by Types (2015-2020)
Table Global Duchenne Muscular Dystrophy Drugs Market Forecast Sales by Types (2020-2025)
Table Global Duchenne Muscular Dystrophy Drugs Market Forecast Sales Share by Types (2020-2025)
Table Global Duchenne Muscular Dystrophy Drugs Market Forecast Revenue ($) by Types (2020-2025)
Table Global Duchenne Muscular Dystrophy Drugs Market Forecast Revenue Share by Types (2020-2025)
Figure Global Exondys51 Sales and Growth Rate (2015-2020)
Figure Global Exondys51 Price (2015-2020)
Figure Global Translarna Sales and Growth Rate (2015-2020)
Figure Global Translarna Price (2015-2020)
Figure Global Emflaza Sales and Growth Rate (2015-2020)
Figure Global Emflaza Price (2015-2020)
Figure Global Duchenne Muscular Dystrophy Drugs Market Revenue ($) and Growth Rate Forecast of Exondys51 (2020-2025)
Figure Global Duchenne Muscular Dystrophy Drugs Sales and Growth Rate Forecast of Exondys51 (2020-2025)
Figure Global Duchenne Muscular Dystrophy Drugs Market Revenue ($) and Growth Rate Forecast of Translarna (2020-2025)
Figure Global Duchenne Muscular Dystrophy Drugs Sales and Growth Rate Forecast of Translarna (2020-2025)
Figure Global Duchenne Muscular Dystrophy Drugs Market Revenue ($) and Growth Rate Forecast of Emflaza (2020-2025)
Figure Global Duchenne Muscular Dystrophy Drugs Sales and Growth Rate Forecast of Emflaza (2020-2025)
Table Global Duchenne Muscular Dystrophy Drugs Sales by Applications (2015-2020)
Table Global Duchenne Muscular Dystrophy Drugs Sales Share by Applications (2015-2020)
Table Global Duchenne Muscular Dystrophy Drugs Revenue ($) by Applications (2015-2020)
Table Global Duchenne Muscular Dystrophy Drugs Revenue Share by Applications (2015-2020)
Table Global Duchenne Muscular Dystrophy Drugs Market Forecast Sales by Applications (2020-2025)
Table Global Duchenne Muscular Dystrophy Drugs Market Forecast Sales Share by Applications (2020-2025)
Table Global Duchenne Muscular Dystrophy Drugs Market Forecast Revenue ($) by Applications (2020-2025)
Table Global Duchenne Muscular Dystrophy Drugs Market Forecast Revenue Share by Applications (2020-2025)
Figure Global Hospitals Sales and Growth Rate (2015-2020)
Figure Global Hospitals Price (2015-2020)
Figure Global Home care settings Sales and Growth Rate (2015-2020)
Figure Global Home care settings Price (2015-2020)
Figure Global Clinics Sales and Growth Rate (2015-2020)
Figure Global Clinics Price (2015-2020)
Figure Global Duchenne Muscular Dystrophy Drugs Market Revenue ($) and Growth Rate Forecast of Hospitals (2020-2025)
Figure Global Duchenne Muscular Dystrophy Drugs Sales and Growth Rate Forecast of Hospitals (2020-2025)
Figure Global Duchenne Muscular Dystrophy Drugs Market Revenue ($) and Growth Rate Forecast of Home care settings (2020-2025)
Figure Global Duchenne Muscular Dystrophy Drugs Sales and Growth Rate Forecast of Home care settings (2020-2025)
Figure Global Duchenne Muscular Dystrophy Drugs Market Revenue ($) and Growth Rate Forecast of Clinics (2020-2025)
Figure Global Duchenne Muscular Dystrophy Drugs Sales and Growth Rate Forecast of Clinics (2020-2025)
Figure Global Duchenne Muscular Dystrophy Drugs Sales and Growth Rate (2015-2020)
Table Global Duchenne Muscular Dystrophy Drugs Sales by Regions (2015-2020)
Table Global Duchenne Muscular Dystrophy Drugs Sales Market Share by Regions (2015-2020)
Figure Global Duchenne Muscular Dystrophy Drugs Sales Market Share by Regions in 2019
Figure Global Duchenne Muscular Dystrophy Drugs Revenue and Growth Rate (2015-2020)
Table Global Duchenne Muscular Dystrophy Drugs Revenue by Regions (2015-2020)
Table Global Duchenne Muscular Dystrophy Drugs Revenue Market Share by Regions (2015-2020)
Figure Global Duchenne Muscular Dystrophy Drugs Revenue Market Share by Regions in 2019
Table Global Duchenne Muscular Dystrophy Drugs Market Forecast Sales by Regions (2020-2025)
Table Global Duchenne Muscular Dystrophy Drugs Market Forecast Sales Share by Regions (2020-2025)
Table Global Duchenne Muscular Dystrophy Drugs Market Forecast Revenue ($) by Regions (2020-2025)
Table Global Duchenne Muscular Dystrophy Drugs Market Forecast Revenue Share by Regions (2020-2025)
Figure North America Duchenne Muscular Dystrophy Drugs Market Sales and Growth Rate (2015-2020)
Figure North America Duchenne Muscular Dystrophy Drugs Market Revenue and Growth Rate (2015-2020)
Figure North America Duchenne Muscular Dystrophy Drugs Market Forecast Sales (2020-2025)
Figure North America Duchenne Muscular Dystrophy Drugs Market Forecast Revenue ($) (2020-2025)
Figure North America COVID-19 Status
Figure U.S. Duchenne Muscular Dystrophy Drugs Market Sales and Growth Rate (2015-2020)
Figure Canada Duchenne Muscular Dystrophy Drugs Market Sales and Growth Rate (2015-2020)
Figure Mexico Duchenne Muscular Dystrophy Drugs Market Sales and Growth Rate (2015-2020)
Figure Europe Duchenne Muscular Dystrophy Drugs Market Sales and Growth Rate (2015-2020)
Figure Europe Duchenne Muscular Dystrophy Drugs Market Revenue and Growth Rate (2015-2020)
Figure Europe Duchenne Muscular Dystrophy Drugs Market Forecast Sales (2020-2025)
Figure Europe Duchenne Muscular Dystrophy Drugs Market Forecast Revenue ($) (2020-2025)
Figure Europe COVID-19 Status
Figure Germany Duchenne Muscular Dystrophy Drugs Market Sales and Growth Rate (2015-2020)
Figure United Kingdom Duchenne Muscular Dystrophy Drugs Market Sales and Growth Rate (2015-2020)
Figure France Duchenne Muscular Dystrophy Drugs Market Sales and Growth Rate (2015-2020)
Figure Italy Duchenne Muscular Dystrophy Drugs Market Sales and Growth Rate (2015-2020)
Figure Spain Duchenne Muscular Dystrophy Drugs Market Sales and Growth Rate (2015-2020)
Figure Russia Duchenne Muscular Dystrophy Drugs Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Duchenne Muscular Dystrophy Drugs Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Duchenne Muscular Dystrophy Drugs Market Revenue and Growth Rate (2015-2020)
Figure Asia-Pacific Duchenne Muscular Dystrophy Drugs Market Forecast Sales (2020-2025)
Figure Asia-Pacific Duchenne Muscular Dystrophy Drugs Market Forecast Revenue ($) (2020-2025)
Figure Asia Pacific COVID-19 Status
Figure China Duchenne Muscular Dystrophy Drugs Market Sales and Growth Rate (2015-2020)
Figure Japan Duchenne Muscular Dystrophy Drugs Market Sales and Growth Rate (2015-2020)
Figure South Korea Duchenne Muscular Dystrophy Drugs Market Sales and Growth Rate (2015-2020)
Figure Australia Duchenne Muscular Dystrophy Drugs Market Sales and Growth Rate (2015-2020)
Figure India Duchenne Muscular Dystrophy Drugs Market Sales and Growth Rate (2015-2020)
Figure South America Duchenne Muscular Dystrophy Drugs Market Sales and Growth Rate (2015-2020)
Figure South America Duchenne Muscular Dystrophy Drugs Market Revenue and Growth Rate (2015-2020)
Figure South America Duchenne Muscular Dystrophy Drugs Market Forecast Sales (2020-2025)
Figure South America Duchenne Muscular Dystrophy Drugs Market Forecast Revenue ($) (2020-2025)
Figure Brazil Duchenne Muscular Dystrophy Drugs Market Sales and Growth Rate (2015-2020)
Figure Argentina Duchenne Muscular Dystrophy Drugs Market Sales and Growth Rate (2015-2020)
Figure Columbia Duchenne Muscular Dystrophy Drugs Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Duchenne Muscular Dystrophy Drugs Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Duchenne Muscular Dystrophy Drugs Market Revenue and Growth Rate (2015-2020)
Figure Middle East and Africa Duchenne Muscular Dystrophy Drugs Market Forecast Sales (2020-2025)
Figure Middle East and Africa Duchenne Muscular Dystrophy Drugs Market Forecast Revenue ($) (2020-2025)
Figure UAE Duchenne Muscular Dystrophy Drugs Market Sales and Growth Rate (2015-2020)
Figure Egypt Duchenne Muscular Dystrophy Drugs Market Sales and Growth Rate (2015-2020)
Figure South Africa Duchenne Muscular Dystrophy Drugs Market Sales and Growth Rate (2015-2020)